Tyche Industries Ltd. (TYCHE) Share Price Falls 8.16% as Micro Cap Stock Turns Top Decliner

Tyche Industries Ltd. traded at Rs 116, down 8.16% today, with a market capitalisation of Rs 129.46 crore and turnover of Rs 0.04 crore on BSE.

Tyche Industries Ltd. Share Price came under pressure on 12 August 2026, with the stock falling to Rs 116 from the previous close of Rs 126.3, a decline of Rs 10.3 or 8.16%. At that level, the company’s market capitalisation stood at Rs 129.46 crore, placing it in the Micro Cap bucket. For readers tracking Tyche Industries Ltd. Share Price Today and Tyche Industries Ltd. Stock News, the move stands out because the stock was flagged under a price fall threshold event rather than a routine intraday fluctuation.

The supplied data confirms what happened in the market: the stock opened at Rs 120.85, touched a day high of Rs 120.85 and then declined to a day low of Rs 116, which also matched the prevailing price at the time of the event. That pattern suggests weakness through the session rather than a brief spike lower. Turnover was Rs 0.04 crore and total traded volume was 3,376 shares, all on BSE.

Why is the stock trending in Stock Market Today searches? The verified data establishes the share price decline and shows Tyche Industries Ltd. among the names drawing attention as a top decliner. However, the supplied figures do not establish a company-specific catalyst for why Tyche Industries Ltd. Share Price is falling today. What investors can monitor next is whether this price action changes only short-term sentiment or begins to alter the market’s view of valuation, profitability and sector positioning. Univest examines those points through price action, fundamental analysis, peer comparison and industry context below.

Tyche Industries Ltd. (TYCHE) Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 116
Previous Close	Rs 126.3
Today's Change	Rs -10.3 (-8.16%)
Day Open	Rs 120.85
Day High	Rs 120.85
Day Low	Rs 116
Current Volume (BSE)	3,376
BSE Traded Volume	3,376
Combined NSE + BSE Volume	3,376
Turnover	Rs 0.04 crore
Market Capitalisation	Rs 129.46 crore
Market Cap Category	Micro Cap

Tyche Industries Ltd. (TYCHE) traded at Rs 116. versus the previous close of Rs 126.3, a fall of 8.16%. The stock opened at Rs 120.85, reached Rs 120.85, touched Rs 116. Reported volume was 3,376.

Tyche Industries Ltd. (TYCHE) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 129.46 crore
P/E Ratio	18.66x
P/B Ratio	0.92x
ROE	23.08%
ROCE	30.89%
EPS	Rs 6.77
Dividend Yield	2.77%

Tyche Industries Ltd. was valued at a P/E ratio of 18.66x, a P/B ratio of 0.92x. These multiples provide valuation context, but they should not be labelled expensive or inexpensive without a comparable peer or sector benchmark.

Profitability and capital efficiency were represented by ROE of 23.08% and ROCE of 30.89%. ROE relates profit to shareholder equity, while ROCE measures returns generated on the capital employed in the business.

Per-share and shareholder-return metrics included EPS of Rs 6.77, dividend yield of 2.77%. Dividend yield is a current or historical ratio and does not guarantee future distributions.

Tyche Industries Ltd. Fundamental Analysis shows a stock that is small in market capitalisation but not obviously stretched on the valuation and return metrics supplied. The current market cap is Rs 129.46 crore, while the P/E ratio stands at 18.66 and the P/B ratio at 0.92, giving investors a useful starting point for judging how the market prices its earnings and net worth.

The market capitalisation of Rs 129.46 crore confirms Tyche Industries Ltd. is a micro-cap company, which matters because price discovery in smaller stocks can be more sensitive to changes in participation and sentiment. On valuation, the P/E ratio of 18.66 means the stock is trading at 18.66 times earnings based on the supplied data. The P/B ratio of 0.92 means the market value is slightly below the accounting book value multiple of one time, which is a notable point when read alongside profitability ratios. Tyche Industries Ltd. Share Price therefore does not look aggressively valued on book value relative to the balance-sheet net worth implied by that ratio.

Profitability metrics are stronger than the valuation multiples alone might suggest. Return on equity is 23.08% and return on capital employed is 30.89%. Those are healthy return figures in absolute terms and indicate that the business has generated solid returns on shareholder capital and overall capital employed based on the latest supplied snapshot. EPS is Rs 6.77, which represents earnings attributable to each share, and gives direct context for the P/E multiple of 18.66. Dividend yield is 2.77, which indicates the historical or current payout relative to the prevailing share price and adds an income dimension to the stock’s profile.

Viewed together, the current Tyche Industries Ltd. Share Price Fall is notable because it comes despite respectable ROE and ROCE and a sub-one P/B ratio. That does not neutralise the day’s weakness, but it does mean investors tracking Tyche Industries Ltd. Financial Results, Tyche Industries Ltd. Earnings and broader Stock Analysis will likely compare today’s fall against the company’s profitability profile rather than looking at price in isolation. The next step is to judge whether sector and peer data support or challenge that interpretation.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Company P/E Ratio	18.66x
Benchmark Median P/E	24.45x
Benchmark Average P/E	79.31x
Benchmark P/E Range	3.31x to 3,374.81x
Company P/B Ratio	0.92x
Benchmark Median P/B	1.82x
Company ROE	23.08%
Benchmark Median ROE	10.49%
Company ROCE	30.89%
Benchmark Median ROCE	12.97%
Company Market Capitalisation	Rs 129.46 crore
Benchmark Median Market Cap	Rs 146.94 crore

Tyche Industries Ltd. (TYCHE) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.

Tyche Industries Ltd. (TYCHE) has a P/E ratio of 18.66x, which is below the benchmark median of 24.45x, a difference of -23.68%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Tyche Industries Ltd. (TYCHE) has a ROE of 23.08%, which is above the benchmark median of 10.49%, a difference of +120.02%. Tyche Industries Ltd. (TYCHE) has a ROCE of 30.89%, which is above the benchmark median of 12.97%, a difference of +138.16%.

Track today's top decliners through the Univest top decliners screener. The peer table below provides the company-level comparison.

Tyche Industries Ltd. operates in Healthcare within the Pharmaceuticals & Drugs industry, and the supplied benchmark offers a broad same-industry comparison across 136 companies. That context matters because today’s share price decline can be judged more meaningfully when set against sector valuation ranges, return benchmarks and market-cap positioning.

The benchmark scope is the same industry, covering 136 companies. Within that basket, Tyche Industries Ltd. carries a P/E of 18.66. That is below the industry median P/E of 24.45 and far below the industry average of 79.31. The average is clearly influenced by high outliers because the industry P/E range runs from 3.31 to 3374.81 across 104 companies with positive or available P/E data. On that measure, Tyche Industries Ltd. Share Price is not being valued at a premium to the typical Pharmaceuticals & Drugs peer group.

The same pattern appears on price to book. The company’s P/B ratio is 0.92 versus an industry median of 1.82 and an average of 2.46 across 135 companies, with the overall range extending from -16.74 to 16.32. That places Tyche Industries below both the median and average P/B for the industry snapshot. By contrast, profitability sits above the benchmark. ROE at 23.08% is well above the median of 10.49% and the average of 8.1. ROCE at 30.89% is similarly stronger than the industry median of 12.97% and average of 15.64.

Market-cap positioning is also revealing. Tyche Industries Ltd. has a market capitalisation of Rs 129.46 crore, below the industry median of Rs 146.94 crore and well below the average of Rs 484.32 crore. The industry market-cap range spans from Rs 6.31 crore to Rs 2,949.87 crore. So, Tyche Industries Ltd. sits on the smaller side of its sector but shows profitability ratios above the industry’s central tendency, while trading at lower valuation multiples. For readers following Tyche Industries Ltd. Share Price News, that combination is one reason today’s decline stands out in Market News screens.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Dishman Carbogen Amcis Ltd.	DCAL	2,949.87	31.07	0.45	-2.89	-0.26
Beta Drugs Ltd.	BETA	2,775.9	71.31	11.28	18.65	22.17
Hikal Ltd.	HIKAL	2,761.32	0	2.26	15.22	16.15
Sai Parenteral's Ltd.	SAIPARENT	2,594.65	179.52	3.32	13.9	12.97
Solara Active Pharma Sciences Ltd.	SOLARA	2,474.65	0	1.92	17.23	15.34

Tyche Industries Ltd. (TYCHE) has a P/E ratio of 18.66x compared with the displayed peer median of 31.07x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 23.08% compares with a peer median of 15.22% across the companies shown in the table. ROCE stood at 30.89% versus the displayed peer median of 15.34%, providing a capital-efficiency comparison. Tyche Industries Ltd. (TYCHE) has a market capitalisation of Rs 129.46 crore. Among the 5 peers shown, 5 have a larger market capitalisation.

Peer comparison shows Tyche Industries Ltd. against a group of listed Pharmaceuticals & Drugs companies with much larger market capitalisations. That makes the comparison useful mainly for relative valuation and profitability, not for direct scale equivalence, because the subject company is materially smaller than the peers listed in the supplied benchmark set.

Tyche Industries Ltd. has a market capitalisation of Rs 129.46 crore, far below Dishman Carbogen Amcis Ltd. at Rs 2,949.87 crore, Beta Drugs Ltd. at Rs 2,775.9 crore, Hikal Ltd. at Rs 2,761.32 crore, Sai Parenteral's Ltd. at Rs 2,594.65 crore and Solara Active Pharma Sciences Ltd. at Rs 2,474.65 crore. Even within that scale gap, the valuation numbers remain relevant. Tyche Industries trades at 18.66 times earnings, lower than Dishman Carbogen Amcis at 31.07, Beta Drugs at 71.31 and Sai Parenteral's at 179.52. Hester Biosciences, at 15.51, is one of the few supplied peers with a lower P/E.

On price to book, Tyche Industries at 0.92 trades above Dishman Carbogen Amcis at 0.45 but below Beta Drugs at 11.28, Hikal at 2.26, Sai Parenteral's at 3.32, Solara at 1.92, Panacea Biotec at 2.95, NGL Fine-Chem at 6.49, Hester Biosciences at 4.64, Ind-Swift Laboratories at 1.65 and Indoco Remedies at 1.99. Profitability also compares reasonably well. Tyche Industries’ ROE of 23.08% is above Beta Drugs at 18.65, Hikal at 15.22, Sai Parenteral's at 13.9, Solara at 17.23, Panacea Biotec at 0, Hester Biosciences at 16.17 and Indoco Remedies at 12.85, though below NGL Fine-Chem at 27.9. ROCE at 30.89% is above most named peers and trails only NGL Fine-Chem at 33.91 among the supplied figures.

That peer picture suggests the Tyche Industries Ltd. Share Price Fall occurred in a stock whose reported profitability ratios compare better than many larger peers, while valuation remains moderate to low on the supplied metrics. Univest views that as an important contrast for investors tracking Tyche Industries Ltd. Stock Performance and Tyche Industries Ltd. Latest News.

Why Investors Are Watching Tyche Industries Ltd.

Investors are watching Tyche Industries Ltd. because today’s decline is sharp enough to place the stock in the top decliner conversation, yet the supplied valuation and return ratios do not present an obviously expensive business. In other words, the market move is clear, but the broader analytical picture is more mixed and therefore worth tracking closely on Univest and other Stock Market Today screens.

• Price action: Tyche Industries Ltd. Share Price fell 8.16% from Rs 126.3 to Rs 116, with the day high capped at the opening price of Rs 120.85.
• Volume and turnover: Total BSE volume was 3,376 shares with turnover of Rs 0.04 crore, enough to register the move but still modest in absolute value terms.
• Fundamental context: P/E is 18.66, P/B is 0.92, ROE is 23.08%, ROCE is 30.89%, EPS is Rs 6.77 and dividend yield is 2.77.
• Sector positioning: The stock trades below the same-industry median P/E of 24.45 and median P/B of 1.82, while ROE and ROCE are above industry medians.
• Micro-cap status: With market capitalisation of Rs 129.46 crore, the stock sits below the industry’s average size and can react sharply to changing sentiment.

What should investors monitor next? The key variables are whether Tyche Industries Ltd. Share Price stabilises away from the day low, whether market attention remains elevated after this price fall, and whether future company updates alter the current balance between moderate valuation and relatively strong profitability. That is the lens through which Univest would frame ongoing Tyche Industries Ltd. Share Price Update coverage.

About Tyche Industries Ltd.

Tyche Industries Ltd. operates in the Healthcare sector and is classified within the Pharmaceuticals & Drugs industry. Even with limited descriptive fields, that industry classification provides important context for understanding how the company is evaluated in the market. Pharmaceuticals & Drugs businesses are commonly assessed using profitability ratios, earnings multiples, price-to-book valuation and market-cap positioning, all of which are available in the supplied data for Tyche Industries Ltd.

At a market capitalisation of Rs 129.46 crore, Tyche Industries Ltd. is a smaller listed company relative to many others in its industry benchmark. The same-industry comparison includes 136 companies, with a median market capitalisation of Rs 146.94 crore and an average of Rs 484.32 crore. That means the company sits below the industry’s average size, even though its profitability metrics compare favourably. ROE at 23.08% and ROCE at 30.89% are stronger than the benchmark medians, while valuation remains below median on both P/E and P/B.

For readers looking up Tyche Industries Ltd. Company News, Tyche Industries Ltd. BSE updates and Tyche Industries Ltd. Shareholding Pattern coverage, the key takeaway is that this is a micro-cap pharmaceuticals stock where market attention can shift quickly. Because it belongs to the Healthcare and Pharmaceuticals & Drugs universe, investors usually track not just price action, but also earnings efficiency, capital returns and relative valuation versus direct listed peers. That broader lens is essential when interpreting any one-day Tyche Industries Ltd. Share Price move.

Track Tyche Industries Ltd. Share Price on Univest

Use Tyche Industries Ltd. (TYCHE) live share-price page, Univest top decliners screener, Univest market blogs to review live stock data, top decliners lists and related market analysis.

Investors tracking Tyche Industries Ltd. Share Price can use Univest to follow live price movement, day change, market capitalisation, valuation ratios and broader stock analysis in one place. For a stock that has entered the Top Losers Today conversation, it helps to watch not just the latest price, but also profitability metrics such as ROE and ROCE, valuation indicators like P/E and P/B, and 52-week market behaviour when available.

Univest also helps users monitor Tyche Industries Ltd. Share Price Today alongside sector comparison, peer metrics, company financials and market insights that place a single-session decline in context. For readers searching Tyche Industries Ltd. Stock News, Tyche Industries Ltd. Share News and Tyche Industries Ltd. Share Price Live, that combination of price, fundamentals and peer positioning can be more useful than looking at intraday movement alone.

Frequently Asked Questions

What is Tyche Industries Ltd. Share Price today?

Ans. Tyche Industries Ltd. Share Price was Rs 116 at the time of the event snapshot on 12 August 2026. The stock was down from the previous close of Rs 126.3, reflecting a single-session decline of 8.16%.

Why is Tyche Industries Ltd. Share Price falling today?

Ans. The supplied market data confirms that Tyche Industries Ltd. Share Price fell 8.16% and entered a monitored price-fall event list. However, the figures only establish the decline and trading activity; they do not identify a company-specific catalyst.

How much did Tyche Industries Ltd. stock decline in today’s trade?

Ans. Tyche Industries Ltd. stock declined by Rs 10.3 in absolute terms, moving from Rs 126.3 to Rs 116. On a percentage basis, that translated into an 8.16% share price fall during the recorded trading session.

What were the day high, day low and opening price of Tyche Industries Ltd.?

Ans. The stock opened at Rs 120.85, and that same level was also the day high. It then declined to Rs 116, which was the day low as well as the prevailing price in the supplied snapshot.

What is the market capitalisation of Tyche Industries Ltd.?

Ans. Tyche Industries Ltd. had a market capitalisation of Rs 129.46 crore in the supplied data. That places the company in the Micro Cap category and below the Pharmaceuticals & Drugs industry average market cap of Rs 484.32 crore.

Is Tyche Industries Ltd. expensive based on the supplied valuation data?

Ans. Based on the supplied numbers, Tyche Industries Ltd. trades at a P/E of 18.66 and a P/B of 0.92. Both are below the same-industry median values of 24.45 for P/E and 1.82 for P/B.

How profitable is Tyche Industries Ltd. compared with its industry benchmark?

Ans. The company’s ROE is 23.08% and ROCE is 30.89%. Those figures are higher than the same-industry median ROE of 10.49% and median ROCE of 12.97%, indicating stronger reported profitability than the benchmark midpoint.

What do EPS and dividend yield show for Tyche Industries Ltd.?

Ans. Tyche Industries Ltd. reported EPS of Rs 6.77 and a dividend yield of 2.77 in the supplied dataset. EPS reflects earnings attributable to each share, while dividend yield shows payout relative to the current share price.

How does Tyche Industries Ltd. compare with selected pharma peers?

Ans. Tyche Industries Ltd. is much smaller by market cap than peers such as Dishman Carbogen Amcis, Beta Drugs and Hikal. Yet its P/E of 18.66 is lower than several peers, while ROE and ROCE compare favourably.

Where can investors track Tyche Industries Ltd. Share Price updates?

Ans. Investors can track Tyche Industries Ltd. Share Price updates on Univest using live price data, valuation ratios, peer comparison and sector context. For this session, the key reference points were Rs 116 price, 8.16% decline and Rs 129.46 crore market.